arrow
H

Herman Goossens

Univ Antwerp
H指数:93
被引数:4.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Implementation of hospital antimicrobial stewardship programmes in low- and middle-income countries: a qualitative study from a multi-professional perspective in the Global-PPS network

在低收入和中等收入国家实施医院抗菌药物管理计划:一项来自全球PPS网络的多专业视角的定性研究

2025-04-050
OA
Impact of Pseudomonas aeruginosa carriage on intensive care unit- acquired pneumonia: a European multicentre prospective cohort study

铜绿假单胞菌携带对重症监护室获得性肺炎的影响:一项欧洲多中心前瞻性队列研究

2025-03-010
PRE
Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study

耐碳青霉烯类肠细菌引起血流感染的危险因素: 一项巢式病例对照研究

2024-07-110
OAAI
Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries

在低收入和中等收入国家对引起新生儿败血症的革兰氏阴性菌的三种抗生素联合方案的评估

2024-05-100
OAAI
Cross-border differences in the prevalence and risk factors for carriage of antimicrobial resistance in children attending daycare centers: a point prevalence study in the Netherlands and Belgium
2024-01-242
OAAI
Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries

门诊呼吸道感染抗生素处方的特定疾病质量指标 (ESAC质量指标) 应用于13个欧洲国家的一般实践中的点患病率审核调查

2023-03-146
OAAI
Incidence and clinical and microbiological features of invasive and probable invasive streptococcal group A infections in children and adults in the Brussels-Capital Region, 2005-2020
2023-03-0715
OAAI
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries
2022-09-220
OAAI